Clinical Efficacy of Jianpi Yangxue Qufeng Decoction in Treating Patients with Blood Deficiency and Wind Dryness Type Atopic Dermatitis and Its Effect on Skin Barrier Function
|更新时间:2024-01-04
|
Clinical Efficacy of Jianpi Yangxue Qufeng Decoction in Treating Patients with Blood Deficiency and Wind Dryness Type Atopic Dermatitis and Its Effect on Skin Barrier Function
Chinese Journal of Experimental Traditional Medical FormulaeVol. 24, Issue 13, Pages: 178-182(2018)
WANG Li-fen, YE Jian-zhou, YANG Xue-song. Clinical Efficacy of Jianpi Yangxue Qufeng Decoction in Treating Patients with Blood Deficiency and Wind Dryness Type Atopic Dermatitis and Its Effect on Skin Barrier Function[J]. Chinese journal of experimental traditional medical formulae, 2018, 24(13): 178-182.
DOI:
WANG Li-fen, YE Jian-zhou, YANG Xue-song. Clinical Efficacy of Jianpi Yangxue Qufeng Decoction in Treating Patients with Blood Deficiency and Wind Dryness Type Atopic Dermatitis and Its Effect on Skin Barrier Function[J]. Chinese journal of experimental traditional medical formulae, 2018, 24(13): 178-182. DOI: 10.13422/j.cnki.syfjx.20180722.
Clinical Efficacy of Jianpi Yangxue Qufeng Decoction in Treating Patients with Blood Deficiency and Wind Dryness Type Atopic Dermatitis and Its Effect on Skin Barrier Function
Objective: To study the clinical efficacy of Jianpi Yangxue Qufeng decoction in treating patients with blood deficiency and wind dryness type atopic dermatitis (AD) and its effect on skin barrier function. Method: Totally 132 cases of patients with blood deficiency and wind dryness type ad treated in our hospital from March 2016 to May 2017 were selected and divided into two groups according to group sequential design
with 66 cases in clinical group and 66 in control group. In addition to the external use of albolene
the control group was given Loratadine Tablets
while the clinical group was given Jianpi Yangxue Qufeng decoction. The course of treatment was 4 weeks. The treatment effect
Th1/Th2 cytokines and immunoglobulin E (IgE)
skin barrier function
scoring atopic dermatitis index (SCORAD) and pruritus visual analogue scale (VAS) were compared. Result: Compared with 84.85% in control group
the total effective rate of clinical group was 95.45%. There was a significant increase (P<0.05). Compared with before treatment
interleukin (IL)-4 and IgE of the two groups after treatment decreased
while IL-2 increased (P<0.05). Compared with control group
the levels of IL-4 and IgE in patients of experimental group were lower after treatment
while IL-2 was higher (P<0.05). Compared with before treatment
transepidermal waterloss (TEWL) of the two groups after treatment decreased
while the sebum content and corneous layer water content increased (P<0.05). Compared with control group
the level of TEWL in patients of the experimental group was lower after treatment
while the sebum content and corneous layer water content were higher (P<0.05). Compared with before treatment
SCORAD scores and pruritus VAS scores in the two groups after treatment decreased (P<0.05). Compared with control group
SCORAD and pruritus VAS scores in patients of experimental group were lower after treatment (P<0.05). Conclusion: Jianpi Yangxue Qufeng decoction has a better effect on blood deficiency and wind dryness type AD
and can significantly improve Th1/Th2 cytokines and skin barrier function and reduce skin lesion and itching.
Clinical Efficacy of Zhuyuwan in Treatment of Hyperlipidemia with Syndrome of Phlegm Turbidity and Obstruction
Clinical Randomized Controlled Trial of Traditional Chinese Medicine Compound Shenlong Decoction Granules in Treatment of Idiopathic Pulmonary Fibrosis
Clinical Efficacy of Jinwei Pingchuan Decoction in Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease with Phlegm-heat Obstruction in Lung Syndrome
Clinical Efficacy of Fuyuan Tongluo Prescription in Prevention and Treatment of Restenosis with Collateral Obstruction Syndrome After Interventional Operation of Lower Limb Arteriosclerosis Obliterans
Clinical Efficacy of Tangning Tongluo Tablets for Nonproliferative Diabetic Retinopathy
Related Author
YANG Lele
LUO Danmei
CHEN Jiao
ZHANG Xiaobo
SONG Wei
ZHU Wenyu
ZHOU Xin
LI Xueping
Related Institution
Hospital of Chengdu University of Traditional Chinese Medicine (TCM)
Chengdu University of TCM
Liaoning University of Traditional Chinese Medicine(TCM)
Affiliated Hospital of Liaoning University of TCM
Beijing University of Chinese Medicine Third Affiliated Hospital